Ensysce Biosciences, Inc. SEC filings ENSC
Ensysce Biosciences, Inc. has 547 filings in SEC EDGAR's recent list, going back to Oct 3, 2017. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 18, 2026 | — |
| 4 | Insider transaction | Aug 18, 2026 | Apr 23, 2026 |
| 3 | Initial insider ownership | Aug 10, 2026 | Aug 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 3, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 6, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 29, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 18, 2023 | — |
| 4 | Insider transaction | Mar 6, 2023 | Mar 2, 2023 |
| 4 | Insider transaction | Mar 2, 2023 | Feb 28, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2023 | — |
| 4 | Insider transaction | Feb 1, 2023 | Dec 9, 2022 |
| SC 13G | Ownership over 5% (passive) | Dec 16, 2022 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jul 7, 2022 | — |
| 4 | Insider transaction | Jun 27, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 27, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 27, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 27, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 27, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 27, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | Jun 27, 2022 | Jun 23, 2022 |
| 4 | Insider transaction | May 27, 2022 | May 25, 2022 |
| 3 | Initial insider ownership | May 4, 2022 | Apr 18, 2022 |
| 4 | Insider transaction | Feb 24, 2022 | Feb 17, 2022 |
| 4 | Insider transaction | Feb 24, 2022 | Feb 17, 2022 |
| 4 | Insider transaction | Feb 24, 2022 | Feb 17, 2022 |
| 3 | Initial insider ownership | Feb 15, 2022 | Feb 8, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2022 | — |
| 3 | Initial insider ownership | Feb 9, 2022 | Oct 15, 2021 |
| 4 | Insider transaction | Feb 4, 2022 | Feb 4, 2022 |
| 4 | Insider transaction | Feb 4, 2022 | Feb 4, 2022 |
| 4 | Insider transaction | Feb 4, 2022 | Feb 4, 2022 |
| 4 | Insider transaction | Feb 4, 2022 | Feb 4, 2022 |
| 4 | Insider transaction | Feb 4, 2022 | Feb 4, 2022 |
| 4 | Insider transaction | Feb 4, 2022 | Feb 4, 2022 |
| 4 | Insider transaction | Feb 4, 2022 | Feb 4, 2022 |
| 4 | Insider transaction | Feb 4, 2022 | Feb 4, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 12, 2021 | — |
| SC 13D | Ownership over 5% (active) | Jul 12, 2021 | — |
| SC 13D | Ownership over 5% (active) | Jul 12, 2021 | — |
| SC 13D | Ownership over 5% (active) | Jul 12, 2021 | — |
| SC 13D | Ownership over 5% (active) | Jul 12, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 7, 2021 | — |
| SC 13D | Ownership over 5% (active) | Jul 6, 2021 | — |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 3 | Initial insider ownership | Jul 2, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jun 30, 2021 |
| 4 | Insider transaction | Jul 1, 2021 | Jun 30, 2021 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 10, 2021 | — |
| 4 | Insider transaction | Jun 23, 2020 | Jun 19, 2020 |
| 3 | Initial insider ownership | Apr 8, 2020 | Mar 29, 2020 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2020 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 15, 2019 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2019 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2018 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2018 | — |
| SC 13G | Ownership over 5% (passive) | Feb 13, 2018 | — |
| 4 | Insider transaction | Jan 17, 2018 | Dec 1, 2017 |
| 4 | Insider transaction | Jan 17, 2018 | Jan 15, 2018 |
| 4 | Insider transaction | Jan 17, 2018 | Jan 15, 2018 |
| 4 | Insider transaction | Jan 17, 2018 | Jan 15, 2018 |
| 4 | Insider transaction | Jan 17, 2018 | Jan 15, 2018 |
| SC 13G | Ownership over 5% (passive) | Dec 11, 2017 | — |
| 4 | Insider transaction | Dec 5, 2017 | Dec 5, 2017 |
| 4 | Insider transaction | Dec 5, 2017 | Dec 5, 2017 |
| 4 | Insider transaction | Dec 5, 2017 | Dec 5, 2017 |
| 4 | Insider transaction | Dec 5, 2017 | Dec 5, 2017 |
| 4 | Insider transaction | Dec 5, 2017 | Dec 5, 2017 |
| 3 | Initial insider ownership | Dec 1, 2017 | Dec 1, 2017 |
| 3 | Initial insider ownership | Dec 1, 2017 | Dec 1, 2017 |
| 3 | Initial insider ownership | Dec 1, 2017 | Dec 1, 2017 |
| 3 | Initial insider ownership | Dec 1, 2017 | Dec 1, 2017 |
| 3 | Initial insider ownership | Dec 1, 2017 | Dec 1, 2017 |
| 3 | Initial insider ownership | Dec 1, 2017 | Dec 1, 2017 |
| 3 | Initial insider ownership | Dec 1, 2017 | Dec 1, 2017 |
| 3 | Initial insider ownership | Dec 1, 2017 | Dec 1, 2017 |
Showing 115 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ENSC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1716947
- Former names
- Leisure Acquisition Corp. (until Jun 30, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.